Inhibrx Biosciences

1. INBRX-106 Ph3 start3Q 2026INBRX-106 Ph3 start, 3Q 2026, notable
2. HexAgon readout timing corporate update3Q 2026HexAgon readout timing corporate update, 3Q 2026, notable
3. Ozekibart filing4Q 2026Ozekibart filing, 4Q 2026, notable
4. INBRX-106 readoutOct 23–27, 2026INBRX-106 readout, Oct 23–27, 2026, material
5. Ozekibart interim1Q 2027Ozekibart interim, 1Q 2027, notable
6. INBRX-106 trial start2027INBRX-106 trial start, 2027, notable
7. Ozekibart enrollment done2027Ozekibart enrollment done, 2027, routine
8. Ozekibart PDUFA dateApr 14, 2027Ozekibart PDUFA date, Apr 14, 2027, major
9. INBRX-106 interim2H 2027INBRX-106 interim, 2H 2027, material

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.